Heart Failure Stage Classification
This patient qualifies as Stage B heart failure (Pre-Heart Failure) based on the presence of structural heart disease (regional wall motion abnormalities with akinesis) and an LVEF at the lower limit of normal (51%), but only if they are currently asymptomatic. 1
Understanding the Staging Framework
The 2022 AHA/ACC/HFSA guidelines define heart failure stages based on structural abnormalities and symptom presence, not just ejection fraction alone 1:
Stage B (Pre-Heart Failure) Criteria:
- Structural heart disease present WITHOUT current or previous HF symptoms
- Your patient has clear structural abnormalities:
- Regional wall motion abnormalities (basal to mild inferior, inferolateral, and anterolateral akinesis)
- LVEF of 51% (at lower limits of normal)
The Critical Distinction - Symptoms Matter:
If this patient has NO symptoms (no dyspnea, fatigue, exercise intolerance, orthopnea, edema):
- Stage B heart failure applies
- This represents structural heart disease that has not yet manifested clinically
If this patient HAS or HAD symptoms of heart failure:
- Stage C heart failure applies, regardless of current symptom status
- Once symptomatic, patients remain Stage C even if symptoms resolve with treatment 1
Ejection Fraction Classification
With an LVEF of 51%, this patient falls into the HFpEF range (≥50%) according to the 2022 guidelines 1. However, the LVEF classification only becomes clinically relevant once the patient is symptomatic (Stage C or D).
Important Caveats:
The 51% LVEF is borderline and requires careful interpretation:
- LVEF measurement has significant intra- and inter-observer variability 2, 3
- A single LVEF measurement may be inadequate; trajectory over time is more important 1
- The presence of regional wall motion abnormalities indicates underlying myocardial dysfunction despite the "preserved" global EF
Regional wall motion abnormalities are structural evidence of cardiac disease that qualifies this patient for at least Stage B, even with normal filling pressures 1. These abnormalities suggest prior myocardial injury (possibly from ischemia) and represent objective cardiac dysfunction.
Clinical Implications
For Stage B patients, the focus is prevention of progression to symptomatic heart failure:
- Aggressive risk factor modification
- Treatment of underlying causes (coronary disease if present)
- Consideration of guideline-directed medical therapy depending on etiology
- Serial monitoring for symptom development or LVEF decline
You must determine symptom status to finalize the stage. Ask specifically about:
- Exertional dyspnea or fatigue
- Orthopnea or paroxysmal nocturnal dyspnea
- Lower extremity edema
- Exercise tolerance changes
- Any prior episodes of decompensation
If any symptoms are present or were present in the past, this becomes Stage C heart failure with preserved ejection fraction (HFpEF), which carries different treatment implications and prognosis 1.